Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-14

Clinical Trial Update: Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing once-daily fluorometholone to twice-daily cyclosporine for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • Fluorometholone (fluorometholone)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: COMPLETED